Functional receptors for VIP, GIP, Glucagon-29 and -37 in the HGT-1 human gastric cancer cell line
- 1 January 1986
- Vol. 7, 121-127
- https://doi.org/10.1016/0196-9781(86)90174-9
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Selective disappearance of histamine H2-receptor activity in the human gastric cancer cell line HGT-1 after short-term or chronic treatment by histamine or its H2-antagonistsInflammation Research, 1985
- Interaction of gastric inhibitory polypeptide (GIP) with the insulin-secreting pancreatic beta cell line, in 111: Characteristics of GIP binding sitesLife Sciences, 1985
- Functional GIP receptors in a hamster pancreatic beta cell line, In 111: Specific binding and biological effectsBiochemical and Biophysical Research Communications, 1984
- Irreversible and specific inactivation by AH 22216 of histamine H2 receptors in the human gastric cancer cell line HGT-1Biochemical and Biophysical Research Communications, 1983
- Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1Life Sciences, 1983
- Action of histamine and vasoactive intestinal peptide (VIP), on cyclic AMP in gastric glands isolated from human fetal stomachCellular and Molecular Life Sciences, 1981
- Selective inhibition by somatostatin of cyclic AMP production in rat gastric glandsFEBS Letters, 1980
- N‐terminally extended somatostatin: The primary structure of somatostatin‐28FEBS Letters, 1980
- Isolation and characterization of bovine vasoactive intestinal peptide (VIP)FEBS Letters, 1979
- Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranesFEBS Letters, 1973